Hutch News
Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
October 21, 2019
The pride of Fred Hutch
HIV Vaccine Trials Network veteran Steven Wakefield named a grand marshal in Seattle Pride Parade
Insights from infants could inform HIV vaccine design
Dr. Julie Overbaugh mines decades-old samples to find new clues to effective immune responses to HIV
mRNA: the future of vaccines?
The Gottardo Laboratory, Vaccine and Infectious Disease Division
Teacher, mom — and living immunotherapy proof of principle
Three years ago she was out of options to treat her advanced cancer. Then, she enrolled in an immunotherapy clinical trial.
Using a virus to teach the immune system to kill cancer
‘Exciting’ results from early trial spurs further development of novel vaccine for sarcoma
Nearly half of U.S. men actively infected with HPV, study finds
HPV-linked cancers on the rise in men, but nearly 9 in 10 vaccine-eligible men are unvaccinated
New study looks at how persistent organic pollutants affect vaccines
New Fred Hutch study looks at whether persistent organic pollutants can undercut vaccines
6 questions in cancer immunotherapy
From cancer vaccines to engineered T cells, experts weigh in on the big unknowns
Building a better protein in the hope of better therapies
Researchers design and create donut-shaped proteins from scratch
HPV vaccines work – so why do so few states require them?
Only Virginia, Washington, D.C., and soon, Rhode Island, include the cancer-preventing vaccine as a school requirement
HIV vaccine: Could a few special cells help protect millions of people?
New analysis finds rare immune cells linked to HIV vaccine’s effectiveness
HPV vaccinations save men’s lives, too
Study finds higher HPV immunization rates among women block cancers in men
Flu season will likely be more severe this year, CDC predicts
Strain has mutated, dimming the vaccine’s effectiveness – but it’s still worth it to get one, experts say
Flu shot strategy sends health worker rates soaring at SCCA
Participation climbs to 97 percent, protects vulnerable patients, Fred Hutch infection expert says
Finding better ways to treat, prevent HPV
Fred Hutch’s Dr. Denise Galloway chairs gathering of the brightest minds to discuss new advances in HPV research – and what’s still needed
Containing a terror: Ebola outbreak highlights challenges of vaccine development
Ebola outbreak highlights challenges of vaccine development